1. Molecular biomarkers for predicting outcomes in urothelial carcinoma of the bladder
    Nikhil Sapre et al, 2014, Pathology CrossRef
  2. Molecular substratification of bladder cancer: moving towards individualized patient management
    Anirban P. Mitra, 2016, Therapeutic Advances in Urology CrossRef
  3. Risk Factors and Molecular Features Associated with Bladder Cancer Development
    Anirban P. Mitra et al, 2018, Precision Molecular Pathology of Bladder Cancer CrossRef
  4. Development of a novel six‐long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma
    Xin Gao et al, 2019, Journal of Cellular Biochemistry CrossRef
  5. Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma
    Goot Heah Khor et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
  6. Long-term validation of a molecular progression-associated gene classifier for prediction of muscle invasion in primary non-muscle-invasive bladder cancer
    Ho Won Kang et al, 2017, Oncology Letters CrossRef
  7. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non–muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram
    Jaroslav Juracek et al, 2019, Urologic Oncology: Seminars and Original Investigations CrossRef
  8. Molecular Prognostication in Bladder Cancer
    Anirban P. Mitra et al, 2018, Genitourinary Cancers CrossRef
  9. MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype
    Sara Lenherr et al, 2017, Genes CrossRef
  10. A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I–III Bladder Cancer Patients After Surgical Resection
    Yawei Li et al, 2019, Frontiers in Oncology CrossRef
  11. Gene expression and prognosis in bladder cancer—real progress? Editorial on ‘S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy’
    J.T. Symanowski et al, 2014, Annals of Oncology CrossRef
  12. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma
    Zhenyu Bao et al, 2017, Oncotarget CrossRef
  13. Differential Expression of Oct4 Variants and Pseudogenes in Normal Urothelium and Urothelial Cancer
    Felix Wezel et al, 2013, The American Journal of Pathology CrossRef